NDC 0591-2312
Alvimopan
Alvimopan
Alvimopan is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Alvimopan.
| Product ID | 0591-2312_1533d956-5314-4ec0-9142-83822d5ce3fd |
| NDC | 0591-2312 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Alvimopan |
| Generic Name | Alvimopan |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-12-01 |
| Marketing Category | ANDA / DRUG FOR FURTHER PROCESSING |
| Application Number | ANDA208295 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | ALVIMOPAN |
| Active Ingredient Strength | 12 mg/1 |
| Pharm Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |